Abstract
Cyclophosphamide (CP) and ifosfamide (IF) are widely used antineoplastic agents, but their side-effect of hemorrhagic cystitis (HC) is still encountered as an important problem. Acrolein is the main molecule responsible of this side-effect and mesna (2-mercaptoethane sulfonate) is the commonly used preventive agent. Mesna binds acrolein and prevent its direct contact with uroepithelium. Current knowledge provides information about the pathophysiological mechanism of HC: several transcription factors and cytokines, free radicals and non-radical reactive molecules, as well as poly(adenosine diphosphate-ribose) polymerase (PARP) activation are now known to take part in its pathogenesis. There is no doubt that HC is an inflammatory process, including when caused by CP. Thus, many cytokines such as tumor necrosis factor (TNF) and the interleukin (IL) family and transcription factors such as nuclear factor-κB (NF-κB) and activator protein-1 (AP-1) also play a role in its pathogenesis. When these molecular factors are taken into account, pathogenesis of CP-induced bladder toxicity can be summarized in three steps: (1) acrolein rapidly enters into the uroepithelial cells; (2) it then activates intracellular reactive oxygen species and nitric oxide production (directly or through NF-κB and AP-1) leading to peroxynitrite production; (3) finally, the increased peroxynitrite level damages lipids (lipid peroxidation), proteins (protein oxidation) and DNA (strand breaks) leading to activation of PARP, a DNA repair enzyme. DNA damage causes PARP overactivation, resulting in the depletion of oxidized nicotinamide–adenine dinucleotide and adenosine triphosphate, and consequently in necrotic cell death. For more effective prevention against HC, all pathophysiological mechanisms must be taken into consideration.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AP-1:
-
activator protein-1
- CAT:
-
catalase
- CP:
-
cyclophosphamide
- eNOS:
-
endothelial nitric oxide synthase
- EPCG:
-
epigallocatechin 3-gallate
- GSH:
-
glutathione
- GSH-Px:
-
glutathione peroxidase
- HC:
-
hemorrhagic cystitis
- IF:
-
ifosfamide
- IL-1:
-
interleukin-1
- iNOS:
-
inducible nitric oxide synthase
- MDA:
-
malondialdehyde
- mesna:
-
2-mercaptoethane sulfonate
- NAD+ :
-
nicotinamide–adenine dinucleotide
- NF-κB:
-
nuclear factor-κB
- nNOS:
-
neuronal nitric oxide synthase
- NO:
-
nitric oxide
- NOS:
-
nitric oxide synthase
- O2 − :
-
superoxide anion (radical)
- ONOO− :
-
peroxynitrite
- ONOOH:
-
peroxynitrous acid
- PAF:
-
platelet-activating factor
- PARP:
-
poly(adenosine diphosphate-ribose) polymerase
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
- TNF-α:
-
tumor necrosing factor alpha
References
Adams JD Jr, Klaidman LK. Acrolein-induced oxygen radical formation. Free Radic Biol Med. 1993;15:187–93.
Batista CK, Mota JM, Souza ML, et al. Amifostine and glutathione prevent ifosfamide-and acrolein-induced hemorrhagic cystitis. Cancer Chemother Pharmacol. 2007;59:71–7.
Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424–37.
Biswal S, Acquaah-Mensah G, Datta K, Wu X, Kehrer JP. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem Res Toxicol. 2002;15:180–6.
Brock N, Pohl J, Stekar J. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer. 1981;17:595–607.
Canman CE, Kastan MB. Signal transduction. Three paths to stress relief. Nature. 1996;384:213–4.
Coggins PR, Ravdin RG, Eisman SH. Clinical evaluation of a new alkylating agent: cytoxan (cyclophosphamide). Cancer. 1960;13:1254–60.
Gomes TNA, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA. Participation of TNF-α and IL-1 in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis. Braz J Med Biol Res. 1995;28:1103–8.
Gray KJ, Engelmann UH, Johnson EH, Fishman IJ. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (cytoxan) therapy. J Urol. 1986;136:497–500.
Horton ND, Mamiya BD, Kehrer JP. Relationships between cell density, glutathione, and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology. 1997;122:111–22.
Horton ND, Biswal SS, Corrigan LL, Bratta J, Kehrer JP. Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J Biol Chem. 1999;274:9200–6.
Kanat O, Kurt E, Yalcinkaya U, Evrensel T, Manavoglu O. Comparison of uroprotective efficacy of mesna and amifostine in cyclophosphamide-induced hemorrhagic cystitis in rats. Indian J Cancer. 2006;43:12–15.
Kehrer JP, Biswal SS. The molecular effects of acrolein. Toxicol Sci. 2000;57:6–15.
Korkmaz A, Oter S, Deveci S, et al. Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol. 2003;170:2498–502.
Korkmaz A, Oter S, Sadir S, et al. Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol. 2005;173:1793–6.
Levine AL, Richie PJ. Urological complications of cyclophosphamide. J Urol. 1989;141:1063–9.
Liu Z. Molecular mechanism of TNF signaling and beyond. Cell Res. 2005;15:24–7.
May MJ, Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol. 1997;8:63–73.
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109–42.
Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bilgic H. Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Urol Res. 2004;32:185–9.
Ozcan A, Korkmaz A, Oter S, Coskun O. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol. 2005;79:461–5.
Radi R, Peluffo G, Alvarez MN, Naviliat M, Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med. 2001;30:463–88.
Ribeiro RA, Feritas HC, Campos MC, et al. Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol. 2002;167:2229–34.
Sadir S, Deveci S, Korkmaz A, Oter S. Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct. 2006; DOI: 10.1027/cbf.1347.
Schraufstatter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest. 1988;82:1040–50.
Sener G, Sehirli O, Yegen BC, Cetinel S, Gedik N, Sakarcan A. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats. J Pineal Res. 2004;37:17–25.
Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82:291–5.
Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27:916–21.
Souza-Filho MV, Lima MV, Pompeu MM, Ballejo G, Cunha FQ, Riberio RA. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am J Pathol. 1997;150:247–56.
Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia—reperfusion injury. Shock. 1996;6:79–88.
Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003;140–141:105–12.
Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA. 1996;93:1753–8.
Takamoto S, Sakura N, Namere A, Yashiki M. Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;806:59–63.
Topal T, Oztas Y, Korkmaz A, et al. Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res. 2005;38:272–7.
Vieira MM, Macêdo FY, Filho JN, et al. Ternatin, a flavonoid, prevents cyclophosphamide and ifosfamide-induced hemorrhagic cystitis in rats. Phytother Res. 2004;18:135–41.
Virag L, Szabo C. The therapeutic potential of poly(ADPRibose) polymerase inhibitors. Pharmacol Rev. 2002;54:375–429.
Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol. 2004;54:469–73.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korkmaz, A., Topal, T. & Oter, S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol 23, 303–312 (2007). https://doi.org/10.1007/s10565-006-0078-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-006-0078-0